205 related articles for article (PubMed ID: 38368115)
1. Chitosan-based nanosystems for cancer diagnosis and therapy: Stimuli-responsive, immune response, and clinical studies.
Moghaddam FD; Zare EN; Hassanpour M; Bertani FR; Serajian A; Ziaei SF; Paiva-Santos AC; Neisiany RE; Makvandi P; Iravani S; Xu Y
Carbohydr Polym; 2024 Apr; 330():121839. PubMed ID: 38368115
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics.
Wei D; Sun Y; Zhu H; Fu Q
ACS Nano; 2023 Dec; 17(23):23223-23261. PubMed ID: 38041800
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
[No Abstract] [Full Text] [Related]
4. Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy.
Lai C; Lin S; Liu W; Jin Y
Curr Med Chem; 2024; 31(21):3074-3092. PubMed ID: 37062062
[TBL] [Abstract][Full Text] [Related]
5. Nanosystems Based on Magnetic Nanoparticles and Thermo- or pH-Responsive Polymers: An Update and Future Perspectives.
Mai BT; Fernandes S; Balakrishnan PB; Pellegrino T
Acc Chem Res; 2018 May; 51(5):999-1013. PubMed ID: 29733199
[TBL] [Abstract][Full Text] [Related]
6. Rationally-designed Chitosan-based Polymeric Nanomaterials According to Intrinsic Characteristics for Cancer Therapy and Theranostics: A Review.
Yu F; Zhu Y; Shang X; Yuan H; Hu F
Curr Med Chem; 2023; 30(12):1368-1385. PubMed ID: 35726412
[TBL] [Abstract][Full Text] [Related]
7. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
Sun X; Zhang G; Wu Z
Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer.
Fathi M; Majidi S; Zangabad PS; Barar J; Erfan-Niya H; Omidi Y
Med Res Rev; 2018 Sep; 38(6):2110-2136. PubMed ID: 29846948
[TBL] [Abstract][Full Text] [Related]
9. Biotinylated chitosan macromolecule based nanosystems: A review from chemical design to biological targets.
Balan V; Dodi G; Mihai CT; Serban AM; Ursachi VC
Int J Biol Macromol; 2021 Oct; 188():82-93. PubMed ID: 34363823
[TBL] [Abstract][Full Text] [Related]
10. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
Tian B; Hua S; Liu J
Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-based nanoparticles for tumor-targeted drug delivery.
Prabaharan M
Int J Biol Macromol; 2015 Jan; 72():1313-22. PubMed ID: 25450550
[TBL] [Abstract][Full Text] [Related]
12. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting strategies for chitosan-based nanoparticles.
Zhang X; Yang X; Ji J; Liu A; Zhai G
Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
[TBL] [Abstract][Full Text] [Related]
14. Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer.
Rosenkrans ZT; Ferreira CA; Ni D; Cai W
Adv Healthc Mater; 2021 Mar; 10(5):e2000690. PubMed ID: 32691969
[TBL] [Abstract][Full Text] [Related]
15. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.
Mi P
Theranostics; 2020; 10(10):4557-4588. PubMed ID: 32292515
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer.
Padya BS; Pandey A; Pisay M; Koteshwara KB; Chandrashekhar Hariharapura R; Bhat KU; Biswas S; Mutalik S
Eur J Pharmacol; 2021 Jan; 890():173633. PubMed ID: 33049302
[TBL] [Abstract][Full Text] [Related]
17. Recent advances of chitosan-based nanoparticles for biomedical and biotechnological applications.
Gao Y; Wu Y
Int J Biol Macromol; 2022 Apr; 203():379-388. PubMed ID: 35104473
[TBL] [Abstract][Full Text] [Related]
18. Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review.
Imran H; Tang Y; Wang S; Yan X; Liu C; Guo L; Wang E; Xu C
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202616
[TBL] [Abstract][Full Text] [Related]
19. Endogenous stimuli-responsive nanoparticles for cancer therapy: From bench to bedside.
Xie F; Wang M; Chen Q; Chi T; Zhu S; Wei P; Yang Y; Zhang L; Li X; Liao Z
Pharmacol Res; 2022 Dec; 186():106522. PubMed ID: 36283629
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications.
Zhao L; Liu H; Xing Y; Wang R; Cheng Z; Lv C; Lv Z; Yu F
J Biomed Nanotechnol; 2020 Sep; 16(9):1325-1358. PubMed ID: 33419489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
